Who Owns Paragon Care Company?

Paragon Care Bundle

Get Full Bundle:

	BCG	$15	$10
	5 FORCES	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Paragon Care Company?

Paragon Care Limited, a significant player in the Australian and New Zealand healthcare sector, underwent a major transformation on June 3, 2024, with the completion of a reverse acquisition of CH2 Holdings Pty Ltd. This strategic move has significantly altered the company's ownership structure, impacting its governance and future direction. As a provider of essential healthcare equipment, devices, and consumables, understanding Paragon Care's ownership is key to grasping its influence and accountability in the market.

The question of who owns Paragon Care is central to understanding its strategic direction and accountability within the dynamic healthcare landscape. Company ownership directly influences control, profit distribution, and the long-term vision pursued by the organization. Following the reverse acquisition of CH2 Holdings, a substantial portion of Paragon Care is now held by the former owners of CH2 Holdings, a development that has profoundly reshaped its governance and future trajectory.

Paragon Care's journey began in 1994 with a vision to supply a comprehensive range of products and services to healthcare facilities. The company's growth has been substantial, culminating in its listing on the Australian Securities Exchange (ASX: PGC). As of July 18, 2025, Paragon Care boasts a market capitalization of approximately A$414 million, with trailing twelve-month revenue reaching $3.06 billion as of December 31, 2024. This financial scale underscores the importance of its ownership structure. The reverse acquisition means that the former owners of CH2 Holdings are now significant stakeholders, influencing the company's strategic decisions and operational focus. This shift is particularly relevant when considering the company's product offerings, such as those analyzed in the Paragon Care BCG Matrix. Understanding the Paragon Care ownership is vital for investors and industry observers alike, as it sheds light on the company's direction and its position within the broader healthcare market. The Paragon Care company owner is now a more complex entity, reflecting the integration of CH2 Holdings. This has led to a new Paragon Care company majority owner structure, impacting the overall Paragon Care shareholding information. The Paragon Care acquisition ownership details highlight this significant change, making the Paragon Care parent company ownership a key area of interest for those tracking the company's performance and strategic initiatives.

The ownership structure of Paragon Care is a critical factor for stakeholders. The company's history of ownership, from its founding to its current publicly traded status, reveals a path of strategic growth and consolidation. The recent reverse acquisition has introduced new major shareholders and potentially altered the influence of existing Paragon Care stakeholders. Examining the Paragon Care board of directors is also important, as they play a crucial role in exercising voting power and guiding the company's strategic direction. For those seeking to understand who is the current owner of Paragon Care, it's essential to look at the post-acquisition shareholding information. The Paragon Care controlling interest owner is now a key question, especially for potential investors or partners. The Paragon Care company history ownership demonstrates a clear evolution, with the recent transaction being a pivotal moment. The Paragon Care founder and ownership aspects are also part of this narrative, though the acquisition has undoubtedly shifted the balance of control. The Paragon Care acquisition ownership details are central to understanding the current landscape. Whether there is Paragon Care private equity ownership or Paragon Care institutional investors ownership involved, these details provide a clearer picture of the company's financial backing and strategic alliances. Ultimately, understanding the Paragon Care beneficial ownership information is key to comprehending the company's governance and future prospects.

Paragon Care Limited, initially incorporated in 1994, has a history that predates its current identity. The company was formerly known as Citrofresh International Limited, a name it held until June 2008 when it transitioned to Paragon Care Limited. While the company's early growth was marked by a strategy of acquiring businesses within the healthcare sector, such as Axis Health, which supplied durable products to hospitals and aged care facilities, specific details regarding its original founders and their initial equity stakes are not extensively documented in recent public records. The focus of current investor information tends to be on periods following its public listing and subsequent mergers.

The early ownership structure of Paragon Care, or its predecessor Citrofresh International, is not clearly outlined in readily available annual reports. It is understood that the company's founding ownership was likely structured to support its ambitious growth plan, which involved the progressive acquisition of healthcare businesses. This suggests that early investors or backers played a crucial role in enabling these initial strategic moves. However, precise information about the names of the founders, their professional backgrounds, or the exact percentage of shares they held at the company's inception is not publicly disclosed in the most recent financial disclosures.

Company's Original Incorporation

Paragon Care Limited was first incorporated in 1994. Its early operations were under the name Citrofresh International Limited.

Name Change and Rebranding

The company officially changed its name to Paragon Care Limited in June 2008. This rebranding marked a new phase for the organization.

Early Growth Strategy

Paragon Care's initial growth was driven by acquiring businesses in the healthcare sector. This expansionist approach was a key part of its early development.

Acquisition of Axis Health

An early strategic acquisition was Axis Health, a company that provided durable products to hospitals and aged care facilities. This acquisition bolstered its market presence.

Limited Founder Information

Detailed information about the original founders of Paragon Care or Citrofresh International is not readily available in recent public filings. Specific equity splits at inception are also not extensively disclosed.

Focus on Post-Listing Era

Current investor information primarily concentrates on the company's performance and ownership structure after its public listing and subsequent mergers, rather than its earliest days.

The lack of detailed founder information in current public records means that the precise ownership structure at the very inception of Paragon Care, or its predecessor Citrofresh International, remains largely undocumented for public scrutiny. This historical gap is common for companies that have undergone significant transformations and mergers over time, with later-stage investors and public market data often overshadowing the initial founding ownership details. Understanding the Competitors Landscape of Paragon Care can provide context for its strategic decisions during its early growth phases.

Paragon Care SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership structure of Paragon Care Limited (ASX: PGC) has seen significant shifts, most notably with its initial public offering and a recent transformative reverse acquisition. While the exact IPO date is not uniformly reported, it's understood to have occurred around October 14, 1999, or March 31, 2021, depending on the interpretation of its listing or a major re-listing event. The most impactful change to its ownership occurred on June 3, 2024, when Paragon Care completed a reverse acquisition of CH2 Holdings Pty Ltd. This transaction involved Paragon Care acquiring all issued shares of CH2 Holdings and, in return, issuing 943,524,072 ordinary shares in Paragon Care to the CH2 vendors. Consequently, the former CH2 vendors now hold a combined 57% of Paragon Care.

This reverse acquisition has resulted in a highly concentrated ownership landscape. As of May 4, 2025, insiders, including executives, board members, and affiliated parties, collectively own approximately 69% of the company's shares. Peter Lacaze, the current Chairman of Paragon Care, and David Collins, the Managing Director & CEO, were each 50% shareholders of CH2 Holdings before the acquisition. Following the transaction, they each hold 28.5% of Paragon Care, positioning them as significant individual shareholders with substantial influence. Other key insiders with notable stakes include Executive Director John Walstab and Chief Operating Officer Carmen Riley. While institutional investors are present, their holdings are smaller. As of May 30, 2025, Paragon Care had 11 institutional owners, collectively holding 7,152,478 shares, with notable participants including Dfa Investment Trust Co and WisdomTree International SmallCap Dividend Fund. This ownership evolution strongly aligns the interests of the company's leadership with its stock performance and strategic direction.

The current ownership structure of Paragon Care reflects a significant concentration of control within its executive leadership and the former owners of CH2 Holdings. This arrangement places a strong emphasis on insider alignment with the company's future performance, a key aspect of understanding Mission, Vision & Core Values of Paragon Care.

Paragon Care Ownership Snapshot

The ownership of Paragon Care is heavily influenced by its recent reverse acquisition. Insiders and former CH2 Holdings vendors hold the majority of shares.

• Majority ownership rests with insiders and former CH2 vendors.
• Peter Lacaze and David Collins are significant individual shareholders.
• Institutional investors hold a smaller portion of the company's shares.
• The ownership structure aligns executive wealth with company performance.

Paragon Care PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Board of Directors for Paragon Care Limited is instrumental in guiding the company's strategic direction, particularly following a significant merger. This governance structure is designed to oversee the company's operations and ensure accountability to its shareholders. The current composition reflects recent changes aimed at strengthening leadership and operational oversight.

As of the latest available information, the board includes key individuals who also hold substantial ownership stakes, indicating a strong alignment between management and ownership. This concentration of ownership among board members significantly influences the company's decision-making processes and overall corporate strategy. Understanding who owns Paragon Care and how that ownership translates to board influence is crucial for assessing the company's future trajectory.

The voting power within Paragon Care is largely influenced by its concentrated ownership structure. With Peter Lacaze and David Collins each holding 28.5% of the company's shares, their combined 57% ownership gives them significant control over shareholder resolutions. This substantial insider ownership, totaling 69% among executives and board members as of May 2025, means that key decision-makers are also major shareholders, aligning their interests directly with the company's performance. This structure typically leads to a more unified approach to corporate governance and strategic planning, as detailed in discussions about the Revenue Streams & Business Model of Paragon Care.

Key Ownership Dynamics

The ownership structure of Paragon Care is characterized by significant concentration among its leadership. This concentration directly impacts voting power and strategic decision-making.

• Peter Lacaze and David Collins are the largest shareholders, each holding 28.5% of the company.
• Combined, these two individuals represent a majority of the voting power.
• Insider ownership, including board members and executives, accounts for approximately 69% of the company's shares as of May 2025.
• This high level of insider control suggests a strong alignment of interests between ownership and management.

Paragon Care Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the last three to five years, Paragon Care's ownership landscape has undergone significant transformations, primarily driven by strategic mergers and shifts in leadership. A pivotal moment was the reverse acquisition of CH2 Holdings Pty Ltd, finalized on June 3, 2024. This transaction resulted in the issuance of more than 943 million new shares to CH2 vendors, granting former CH2 shareholders a 57% stake in the newly combined entity. Consequently, CH2 Holdings became the accounting acquirer, integrating its pharmaceutical and medical consumables distribution operations with Paragon Care's existing healthcare equipment portfolio. This strategic move aims to broaden the company's market reach across Australia, New Zealand, and Asia.

These structural changes have been paralleled by leadership transitions. David Collins, formerly the CEO of CH2 Holdings, assumed the role of Managing Director & CEO of the merged Paragon Care in June 2024, holding a substantial 28.5% ownership interest. More recently, Carmen Riley, who served as Chief Operating Officer/Executive Director, was appointed as the new Chief Executive Officer/Executive Director, effective July 1, 2025, taking over from David Collins, who will continue as Managing Director. John Walstab transitioned from his CEO/MD position at Paragon Care to an Executive Director role until March 31, 2025, following the merger. Notably, insider buying activity between October 2023 and March 2025, even amidst a stock price decline, suggests a strong conviction in the company's future prospects from key insiders such as John Walstab and Carmen Riley.

Industry trends are also influencing Paragon Care's trajectory. While there's a general increase in institutional ownership within the healthcare sector, Paragon Care currently exhibits a strong insider ownership dominance at 69%. The broader healthcare market, fueled by an aging demographic, escalating consumer expectations, and increased government expenditure across Australia, New Zealand, and Asia, presents a supportive environment for growth and consolidation. Paragon Care is projecting annual synergies of $5 million in FY25 and $12 million in FY26 from the CH2 merger, reflecting a focus on operational efficiencies and achieving greater scale. The company anticipates continued organic growth in FY2024 and accelerated growth in FY2025, with a strategic target of reaching $100 million in EBITDA by FY2027 through a combination of organic expansion and further strategic acquisitions, aligning with its Growth Strategy of Paragon Care.

Paragon Care Ownership Structure

The ownership of Paragon Care has been significantly reshaped by the recent reverse acquisition of CH2 Holdings. This event has led to a majority stake being held by former CH2 shareholders, altering the company's controlling interest owner.

Key Stakeholders and Leadership

David Collins, formerly of CH2 Holdings, now serves as Managing Director & CEO, holding a substantial ownership percentage. Carmen Riley's recent appointment as CEO further highlights the evolving executive leadership and their direct stake in the company's performance.

Insider Confidence and Future Outlook

Despite market fluctuations, significant insider buying activity between October 2023 and March 2025 indicates strong confidence from key individuals like John Walstab and Carmen Riley. This suggests a belief in the company's long-term growth potential and strategic direction.

Market Trends and Synergies

Paragon Care is strategically positioned to benefit from an aging population and increased healthcare spending. The company anticipates substantial synergies from the CH2 merger, aiming for $5 million in FY25 and $12 million in FY26, underscoring a focus on operational efficiency and scale.

Paragon Care Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔